Anaplastic Thyroid Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-05-01
Clinical Trial Update: Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer [Phase 3]
The Phase 3 trial of fosbretabulin or placebo in combination with carboplatin/paclitaxel for anaplastic thyroid cancer has been withdrawn.